You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

14 April 2021

COVID-19 vaccine batch release information is now available.

26 March 2021

Understand the regulatory process of how a COVID-19 vaccine application is submitted and assessed before a vaccine is approved for supply in Australia.

26 March 2021
The TGA has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine
26 March 2021
The TGA has granted provisional approval to Pfizer Australia Pty Ltd for its COVID-19 vaccine, COMIRNATY, making it the first COVID-19 vaccine to receive regulatory approval in Australia.
26 February 2021
The TGA has received applications and is assessing preliminary data for three COVID-19 vaccines using the provisional pathway and rolling review procedures.
22 February 2021

Find information on complying with the rules around advertising and importing COVID-19 vaccines

16 February 2021
The TGA has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine
9 February 2021
The plan outlines five key strategies to strengthen Australia's vaccine vigilance system.
9 February 2021
At the time of approving a vaccine, the TGA publishes extensive information about the product for both health professionals and the public.
9 February 2021
A comprehensive system is in place to capture reports of adverse events following COVID-19 vaccination.

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us